chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 78.0
Sex: M
Vaccine: COVID19, FLUC4, COVID19
Symptoms: Acute kidney injury, Asthenia, COVID-19, Decreased appetite, Dehydration
Clinical narrative: Discharge Provider:  Primary Care Provider:  Admission Date: 7/30/2022 Discharge Date: Aug 1, 2022  PRESENTING PROBLEM: COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 79-year-old male with past medical history of hypertension, CKD 3, atrial fibrillation with a new diagnosis of renal mass who presented the hospital with acute COVID-19 infection.  Patient was weak and dehydrated.  Patient had acute on chronic renal failure and was started on IV fluids.  Patient did not meet any criteria for treatment of his COVID-19 infection as he was not hypoxic.  Patient improved on IV fluids, his renal function improved, his energy level improved, and his appetite improved.  Patient was able tolerate general diet on the day of discharge.  Patient renal function was significantly improving.  Patient's ACE inhibitor was held given his acute on chronic renal failure and this was discontinued at the time of discharge.  Patient worked with physical therapy and occupational therapy who recommended home health care.  Patient was then discharged home in stable condition to follow-up with primary care physician as well as his urologist for his newly diagnosed renal mass.
Age: 78.0
Sex: M
Vaccine: COVID19, FLUC4, COVID19
Symptoms: Renal mass
Clinical narrative: Discharge Provider:  Primary Care Provider:  Admission Date: 7/30/2022 Discharge Date: Aug 1, 2022  PRESENTING PROBLEM: COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 79-year-old male with past medical history of hypertension, CKD 3, atrial fibrillation with a new diagnosis of renal mass who presented the hospital with acute COVID-19 infection.  Patient was weak and dehydrated.  Patient had acute on chronic renal failure and was started on IV fluids.  Patient did not meet any criteria for treatment of his COVID-19 infection as he was not hypoxic.  Patient improved on IV fluids, his renal function improved, his energy level improved, and his appetite improved.  Patient was able tolerate general diet on the day of discharge.  Patient renal function was significantly improving.  Patient's ACE inhibitor was held given his acute on chronic renal failure and this was discontinued at the time of discharge.  Patient worked with physical therapy and occupational therapy who recommended home health care.  Patient was then discharged home in stable condition to follow-up with primary care physician as well as his urologist for his newly diagnosed renal mass.
Age: 78.0
Sex: M
Vaccine: COVID19, FLUC4, COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, Anaemia, Ankle brachial index abnormal, Bladder catheterisation
Clinical narrative: Discharge Provider:  Primary Care Provider:  Admission Date: 7/30/2022 Discharge Date: Aug 1, 2022  PRESENTING PROBLEM: COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 79-year-old male with past medical history of hypertension, CKD 3, atrial fibrillation with a new diagnosis of renal mass who presented the hospital with acute COVID-19 infection.  Patient was weak and dehydrated.  Patient had acute on chronic renal failure and was started on IV fluids.  Patient did not meet any criteria for treatment of his COVID-19 infection as he was not hypoxic.  Patient improved on IV fluids, his renal function improved, his energy level improved, and his appetite improved.  Patient was able tolerate general diet on the day of discharge.  Patient renal function was significantly improving.  Patient's ACE inhibitor was held given his acute on chronic renal failure and this was discontinued at the time of discharge.  Patient worked with physical therapy and occupational therapy who recommended home health care.  Patient was then discharged home in stable condition to follow-up with primary care physician as well as his urologist for his newly diagnosed renal mass.
Age: 78.0
Sex: M
Vaccine: COVID19, FLUC4, COVID19
Symptoms: Bladder outlet obstruction, Blister, Blood test abnormal, Bronchiolitis, C-reactive protein increased
Clinical narrative: Discharge Provider:  Primary Care Provider:  Admission Date: 7/30/2022 Discharge Date: Aug 1, 2022  PRESENTING PROBLEM: COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 79-year-old male with past medical history of hypertension, CKD 3, atrial fibrillation with a new diagnosis of renal mass who presented the hospital with acute COVID-19 infection.  Patient was weak and dehydrated.  Patient had acute on chronic renal failure and was started on IV fluids.  Patient did not meet any criteria for treatment of his COVID-19 infection as he was not hypoxic.  Patient improved on IV fluids, his renal function improved, his energy level improved, and his appetite improved.  Patient was able tolerate general diet on the day of discharge.  Patient renal function was significantly improving.  Patient's ACE inhibitor was held given his acute on chronic renal failure and this was discontinued at the time of discharge.  Patient worked with physical therapy and occupational therapy who recommended home health care.  Patient was then discharged home in stable condition to follow-up with primary care physician as well as his urologist for his newly diagnosed renal mass.
Age: 78.0
Sex: M
Vaccine: COVID19, FLUC4, COVID19
Symptoms: COVID-19, Cellulitis, Chronic kidney disease, Computerised tomogram abdomen abnormal, Computerised tomogram thorax abnormal
Clinical narrative: Discharge Provider:  Primary Care Provider:  Admission Date: 7/30/2022 Discharge Date: Aug 1, 2022  PRESENTING PROBLEM: COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 79-year-old male with past medical history of hypertension, CKD 3, atrial fibrillation with a new diagnosis of renal mass who presented the hospital with acute COVID-19 infection.  Patient was weak and dehydrated.  Patient had acute on chronic renal failure and was started on IV fluids.  Patient did not meet any criteria for treatment of his COVID-19 infection as he was not hypoxic.  Patient improved on IV fluids, his renal function improved, his energy level improved, and his appetite improved.  Patient was able tolerate general diet on the day of discharge.  Patient renal function was significantly improving.  Patient's ACE inhibitor was held given his acute on chronic renal failure and this was discontinued at the time of discharge.  Patient worked with physical therapy and occupational therapy who recommended home health care.  Patient was then discharged home in stable condition to follow-up with primary care physician as well as his urologist for his newly diagnosed renal mass.
Age: 78.0
Sex: M
Vaccine: COVID19, FLUC4, COVID19
Symptoms: Condition aggravated, Culture wound positive, Death, Decubitus ulcer, Dyspnoea
Clinical narrative: Discharge Provider:  Primary Care Provider:  Admission Date: 7/30/2022 Discharge Date: Aug 1, 2022  PRESENTING PROBLEM: COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 79-year-old male with past medical history of hypertension, CKD 3, atrial fibrillation with a new diagnosis of renal mass who presented the hospital with acute COVID-19 infection.  Patient was weak and dehydrated.  Patient had acute on chronic renal failure and was started on IV fluids.  Patient did not meet any criteria for treatment of his COVID-19 infection as he was not hypoxic.  Patient improved on IV fluids, his renal function improved, his energy level improved, and his appetite improved.  Patient was able tolerate general diet on the day of discharge.  Patient renal function was significantly improving.  Patient's ACE inhibitor was held given his acute on chronic renal failure and this was discontinued at the time of discharge.  Patient worked with physical therapy and occupational therapy who recommended home health care.  Patient was then discharged home in stable condition to follow-up with primary care physician as well as his urologist for his newly diagnosed renal mass.
Age: 78.0
Sex: M
Vaccine: COVID19, FLUC4, COVID19
Symptoms: Enterovirus infection, Gait disturbance, Gastrointestinal tube insertion, Glycosylated haemoglobin normal, Haemoglobin decreased
Clinical narrative: Discharge Provider:  Primary Care Provider:  Admission Date: 7/30/2022 Discharge Date: Aug 1, 2022  PRESENTING PROBLEM: COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 79-year-old male with past medical history of hypertension, CKD 3, atrial fibrillation with a new diagnosis of renal mass who presented the hospital with acute COVID-19 infection.  Patient was weak and dehydrated.  Patient had acute on chronic renal failure and was started on IV fluids.  Patient did not meet any criteria for treatment of his COVID-19 infection as he was not hypoxic.  Patient improved on IV fluids, his renal function improved, his energy level improved, and his appetite improved.  Patient was able tolerate general diet on the day of discharge.  Patient renal function was significantly improving.  Patient's ACE inhibitor was held given his acute on chronic renal failure and this was discontinued at the time of discharge.  Patient worked with physical therapy and occupational therapy who recommended home health care.  Patient was then discharged home in stable condition to follow-up with primary care physician as well as his urologist for his newly diagnosed renal mass.
Age: 78.0
Sex: M
Vaccine: COVID19, FLUC4, COVID19
Symptoms: Hiatus hernia, Hyporesponsive to stimuli, Impaired healing, Leukocytosis, Lung opacity
Clinical narrative: Discharge Provider:  Primary Care Provider:  Admission Date: 7/30/2022 Discharge Date: Aug 1, 2022  PRESENTING PROBLEM: COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 79-year-old male with past medical history of hypertension, CKD 3, atrial fibrillation with a new diagnosis of renal mass who presented the hospital with acute COVID-19 infection.  Patient was weak and dehydrated.  Patient had acute on chronic renal failure and was started on IV fluids.  Patient did not meet any criteria for treatment of his COVID-19 infection as he was not hypoxic.  Patient improved on IV fluids, his renal function improved, his energy level improved, and his appetite improved.  Patient was able tolerate general diet on the day of discharge.  Patient renal function was significantly improving.  Patient's ACE inhibitor was held given his acute on chronic renal failure and this was discontinued at the time of discharge.  Patient worked with physical therapy and occupational therapy who recommended home health care.  Patient was then discharged home in stable condition to follow-up with primary care physician as well as his urologist for his newly diagnosed renal mass.
Age: 78.0
Sex: M
Vaccine: COVID19, FLUC4, COVID19
Symptoms: Magnetic resonance imaging normal, Malnutrition, Oesophagogastroduodenoscopy abnormal, Oropharyngeal pain, Pain
Clinical narrative: Discharge Provider:  Primary Care Provider:  Admission Date: 7/30/2022 Discharge Date: Aug 1, 2022  PRESENTING PROBLEM: COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 79-year-old male with past medical history of hypertension, CKD 3, atrial fibrillation with a new diagnosis of renal mass who presented the hospital with acute COVID-19 infection.  Patient was weak and dehydrated.  Patient had acute on chronic renal failure and was started on IV fluids.  Patient did not meet any criteria for treatment of his COVID-19 infection as he was not hypoxic.  Patient improved on IV fluids, his renal function improved, his energy level improved, and his appetite improved.  Patient was able tolerate general diet on the day of discharge.  Patient renal function was significantly improving.  Patient's ACE inhibitor was held given his acute on chronic renal failure and this was discontinued at the time of discharge.  Patient worked with physical therapy and occupational therapy who recommended home health care.  Patient was then discharged home in stable condition to follow-up with primary care physician as well as his urologist for his newly diagnosed renal mass.
Age: 78.0
Sex: M
Vaccine: COVID19, FLUC4, COVID19
Symptoms: Pain in extremity, Peripheral artery stenosis, Pleural effusion, Procalcitonin increased, Productive cough
Clinical narrative: Discharge Provider:  Primary Care Provider:  Admission Date: 7/30/2022 Discharge Date: Aug 1, 2022  PRESENTING PROBLEM: COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 79-year-old male with past medical history of hypertension, CKD 3, atrial fibrillation with a new diagnosis of renal mass who presented the hospital with acute COVID-19 infection.  Patient was weak and dehydrated.  Patient had acute on chronic renal failure and was started on IV fluids.  Patient did not meet any criteria for treatment of his COVID-19 infection as he was not hypoxic.  Patient improved on IV fluids, his renal function improved, his energy level improved, and his appetite improved.  Patient was able tolerate general diet on the day of discharge.  Patient renal function was significantly improving.  Patient's ACE inhibitor was held given his acute on chronic renal failure and this was discontinued at the time of discharge.  Patient worked with physical therapy and occupational therapy who recommended home health care.  Patient was then discharged home in stable condition to follow-up with primary care physician as well as his urologist for his newly diagnosed renal mass.
Age: 78.0
Sex: M
Vaccine: COVID19, FLUC4, COVID19
Symptoms: Pseudomonas test positive, Pyrexia, Renal mass, Respiratory tract congestion, Rhinorrhoea
Clinical narrative: Discharge Provider:  Primary Care Provider:  Admission Date: 7/30/2022 Discharge Date: Aug 1, 2022  PRESENTING PROBLEM: COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 79-year-old male with past medical history of hypertension, CKD 3, atrial fibrillation with a new diagnosis of renal mass who presented the hospital with acute COVID-19 infection.  Patient was weak and dehydrated.  Patient had acute on chronic renal failure and was started on IV fluids.  Patient did not meet any criteria for treatment of his COVID-19 infection as he was not hypoxic.  Patient improved on IV fluids, his renal function improved, his energy level improved, and his appetite improved.  Patient was able tolerate general diet on the day of discharge.  Patient renal function was significantly improving.  Patient's ACE inhibitor was held given his acute on chronic renal failure and this was discontinued at the time of discharge.  Patient worked with physical therapy and occupational therapy who recommended home health care.  Patient was then discharged home in stable condition to follow-up with primary care physician as well as his urologist for his newly diagnosed renal mass.
Age: 78.0
Sex: M
Vaccine: COVID19, FLUC4, COVID19
Symptoms: Rhinovirus infection, SARS-CoV-2 test positive, Sinus pain, Skin ulcer, Tachypnoea
Clinical narrative: Discharge Provider:  Primary Care Provider:  Admission Date: 7/30/2022 Discharge Date: Aug 1, 2022  PRESENTING PROBLEM: COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 79-year-old male with past medical history of hypertension, CKD 3, atrial fibrillation with a new diagnosis of renal mass who presented the hospital with acute COVID-19 infection.  Patient was weak and dehydrated.  Patient had acute on chronic renal failure and was started on IV fluids.  Patient did not meet any criteria for treatment of his COVID-19 infection as he was not hypoxic.  Patient improved on IV fluids, his renal function improved, his energy level improved, and his appetite improved.  Patient was able tolerate general diet on the day of discharge.  Patient renal function was significantly improving.  Patient's ACE inhibitor was held given his acute on chronic renal failure and this was discontinued at the time of discharge.  Patient worked with physical therapy and occupational therapy who recommended home health care.  Patient was then discharged home in stable condition to follow-up with primary care physician as well as his urologist for his newly diagnosed renal mass.
Age: 78.0
Sex: M
Vaccine: COVID19, FLUC4, COVID19
Symptoms: Thyroid mass, Upper respiratory tract infection, Viral infection, Wound drainage, Wound haemorrhage
Clinical narrative: Discharge Provider:  Primary Care Provider:  Admission Date: 7/30/2022 Discharge Date: Aug 1, 2022  PRESENTING PROBLEM: COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 79-year-old male with past medical history of hypertension, CKD 3, atrial fibrillation with a new diagnosis of renal mass who presented the hospital with acute COVID-19 infection.  Patient was weak and dehydrated.  Patient had acute on chronic renal failure and was started on IV fluids.  Patient did not meet any criteria for treatment of his COVID-19 infection as he was not hypoxic.  Patient improved on IV fluids, his renal function improved, his energy level improved, and his appetite improved.  Patient was able tolerate general diet on the day of discharge.  Patient renal function was significantly improving.  Patient's ACE inhibitor was held given his acute on chronic renal failure and this was discontinued at the time of discharge.  Patient worked with physical therapy and occupational therapy who recommended home health care.  Patient was then discharged home in stable condition to follow-up with primary care physician as well as his urologist for his newly diagnosed renal mass.
Age: 78.0
Sex: M
Vaccine: COVID19, FLUC4, COVID19
Symptoms: X-ray limb normal
Clinical narrative: Discharge Provider:  Primary Care Provider:  Admission Date: 7/30/2022 Discharge Date: Aug 1, 2022  PRESENTING PROBLEM: COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 79-year-old male with past medical history of hypertension, CKD 3, atrial fibrillation with a new diagnosis of renal mass who presented the hospital with acute COVID-19 infection.  Patient was weak and dehydrated.  Patient had acute on chronic renal failure and was started on IV fluids.  Patient did not meet any criteria for treatment of his COVID-19 infection as he was not hypoxic.  Patient improved on IV fluids, his renal function improved, his energy level improved, and his appetite improved.  Patient was able tolerate general diet on the day of discharge.  Patient renal function was significantly improving.  Patient's ACE inhibitor was held given his acute on chronic renal failure and this was discontinued at the time of discharge.  Patient worked with physical therapy and occupational therapy who recommended home health care.  Patient was then discharged home in stable condition to follow-up with primary care physician as well as his urologist for his newly diagnosed renal mass.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Alanine aminotransferase normal, Aspartate aminotransferase normal, Asymptomatic COVID-19, Blood albumin decreased
Clinical narrative: Pt presented to the ED on 1/23 with CC of abdominal pain and N/V.     IN ED pt with VS of temperature 99°, heart rate 118, respiration rate 16, blood pressure 116/67, and sats 97% on room air.  Labs with white blood cell count elevated at 15.32, absolute neutrophil count elevated at 13.39, potassium low at 3.4, albumin low at 2.8, AST ALT within normal limits, LDH of 174, lactate of 0.9, CRP elevated at 15.10, D-dimer elevated at 2214, ferritin elevated at 337.8, procalcitonin within normal limits at 0.10, influenza a and B PCR negative, RSV PCR negative, COVID-19 PCR positive.  UA appears contaminated and urine cultures currently pending.  C diff PCR positive.  Troponin x4 within normal limits.  EKG with sinus tachycardia, heart rate 111, T-wave abnormalities noted in inferior and lateral leads.  Chest x-ray within normal limits.  CT abdomen pelvis with contrast showed diffuse rocking pharyngeal mucosal thickening of the distal half with descending colon and sigmoid colon possibly due to colitis or diverticulitis extent of mucosal thickening in the colon slightly increased since previous exam. She continued to be asymptomatic for COVID during her hospital stay.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Blood lactate dehydrogenase normal, Blood lactic acid, Blood potassium decreased, C-reactive protein increased, Chest X-ray normal
Clinical narrative: Pt presented to the ED on 1/23 with CC of abdominal pain and N/V.     IN ED pt with VS of temperature 99°, heart rate 118, respiration rate 16, blood pressure 116/67, and sats 97% on room air.  Labs with white blood cell count elevated at 15.32, absolute neutrophil count elevated at 13.39, potassium low at 3.4, albumin low at 2.8, AST ALT within normal limits, LDH of 174, lactate of 0.9, CRP elevated at 15.10, D-dimer elevated at 2214, ferritin elevated at 337.8, procalcitonin within normal limits at 0.10, influenza a and B PCR negative, RSV PCR negative, COVID-19 PCR positive.  UA appears contaminated and urine cultures currently pending.  C diff PCR positive.  Troponin x4 within normal limits.  EKG with sinus tachycardia, heart rate 111, T-wave abnormalities noted in inferior and lateral leads.  Chest x-ray within normal limits.  CT abdomen pelvis with contrast showed diffuse rocking pharyngeal mucosal thickening of the distal half with descending colon and sigmoid colon possibly due to colitis or diverticulitis extent of mucosal thickening in the colon slightly increased since previous exam. She continued to be asymptomatic for COVID during her hospital stay.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Clostridium test positive, Computerised tomogram abdomen abnormal, Culture urine, Electrocardiogram T wave abnormal, Electrocardiogram abnormal
Clinical narrative: Pt presented to the ED on 1/23 with CC of abdominal pain and N/V.     IN ED pt with VS of temperature 99°, heart rate 118, respiration rate 16, blood pressure 116/67, and sats 97% on room air.  Labs with white blood cell count elevated at 15.32, absolute neutrophil count elevated at 13.39, potassium low at 3.4, albumin low at 2.8, AST ALT within normal limits, LDH of 174, lactate of 0.9, CRP elevated at 15.10, D-dimer elevated at 2214, ferritin elevated at 337.8, procalcitonin within normal limits at 0.10, influenza a and B PCR negative, RSV PCR negative, COVID-19 PCR positive.  UA appears contaminated and urine cultures currently pending.  C diff PCR positive.  Troponin x4 within normal limits.  EKG with sinus tachycardia, heart rate 111, T-wave abnormalities noted in inferior and lateral leads.  Chest x-ray within normal limits.  CT abdomen pelvis with contrast showed diffuse rocking pharyngeal mucosal thickening of the distal half with descending colon and sigmoid colon possibly due to colitis or diverticulitis extent of mucosal thickening in the colon slightly increased since previous exam. She continued to be asymptomatic for COVID during her hospital stay.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Fibrin D dimer increased, Influenza A virus test negative, Influenza B virus test, Laboratory test, Mucosal hypertrophy
Clinical narrative: Pt presented to the ED on 1/23 with CC of abdominal pain and N/V.     IN ED pt with VS of temperature 99°, heart rate 118, respiration rate 16, blood pressure 116/67, and sats 97% on room air.  Labs with white blood cell count elevated at 15.32, absolute neutrophil count elevated at 13.39, potassium low at 3.4, albumin low at 2.8, AST ALT within normal limits, LDH of 174, lactate of 0.9, CRP elevated at 15.10, D-dimer elevated at 2214, ferritin elevated at 337.8, procalcitonin within normal limits at 0.10, influenza a and B PCR negative, RSV PCR negative, COVID-19 PCR positive.  UA appears contaminated and urine cultures currently pending.  C diff PCR positive.  Troponin x4 within normal limits.  EKG with sinus tachycardia, heart rate 111, T-wave abnormalities noted in inferior and lateral leads.  Chest x-ray within normal limits.  CT abdomen pelvis with contrast showed diffuse rocking pharyngeal mucosal thickening of the distal half with descending colon and sigmoid colon possibly due to colitis or diverticulitis extent of mucosal thickening in the colon slightly increased since previous exam. She continued to be asymptomatic for COVID during her hospital stay.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Neutrophil count increased, Procalcitonin, Respiratory syncytial virus test negative, SARS-CoV-2 test positive
Clinical narrative: Pt presented to the ED on 1/23 with CC of abdominal pain and N/V.     IN ED pt with VS of temperature 99°, heart rate 118, respiration rate 16, blood pressure 116/67, and sats 97% on room air.  Labs with white blood cell count elevated at 15.32, absolute neutrophil count elevated at 13.39, potassium low at 3.4, albumin low at 2.8, AST ALT within normal limits, LDH of 174, lactate of 0.9, CRP elevated at 15.10, D-dimer elevated at 2214, ferritin elevated at 337.8, procalcitonin within normal limits at 0.10, influenza a and B PCR negative, RSV PCR negative, COVID-19 PCR positive.  UA appears contaminated and urine cultures currently pending.  C diff PCR positive.  Troponin x4 within normal limits.  EKG with sinus tachycardia, heart rate 111, T-wave abnormalities noted in inferior and lateral leads.  Chest x-ray within normal limits.  CT abdomen pelvis with contrast showed diffuse rocking pharyngeal mucosal thickening of the distal half with descending colon and sigmoid colon possibly due to colitis or diverticulitis extent of mucosal thickening in the colon slightly increased since previous exam. She continued to be asymptomatic for COVID during her hospital stay.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Serum ferritin increased, Sinus tachycardia, Troponin normal, Urine analysis abnormal, Vomiting
Clinical narrative: Pt presented to the ED on 1/23 with CC of abdominal pain and N/V.     IN ED pt with VS of temperature 99°, heart rate 118, respiration rate 16, blood pressure 116/67, and sats 97% on room air.  Labs with white blood cell count elevated at 15.32, absolute neutrophil count elevated at 13.39, potassium low at 3.4, albumin low at 2.8, AST ALT within normal limits, LDH of 174, lactate of 0.9, CRP elevated at 15.10, D-dimer elevated at 2214, ferritin elevated at 337.8, procalcitonin within normal limits at 0.10, influenza a and B PCR negative, RSV PCR negative, COVID-19 PCR positive.  UA appears contaminated and urine cultures currently pending.  C diff PCR positive.  Troponin x4 within normal limits.  EKG with sinus tachycardia, heart rate 111, T-wave abnormalities noted in inferior and lateral leads.  Chest x-ray within normal limits.  CT abdomen pelvis with contrast showed diffuse rocking pharyngeal mucosal thickening of the distal half with descending colon and sigmoid colon possibly due to colitis or diverticulitis extent of mucosal thickening in the colon slightly increased since previous exam. She continued to be asymptomatic for COVID during her hospital stay.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: White blood cell count increased
Clinical narrative: Pt presented to the ED on 1/23 with CC of abdominal pain and N/V.     IN ED pt with VS of temperature 99°, heart rate 118, respiration rate 16, blood pressure 116/67, and sats 97% on room air.  Labs with white blood cell count elevated at 15.32, absolute neutrophil count elevated at 13.39, potassium low at 3.4, albumin low at 2.8, AST ALT within normal limits, LDH of 174, lactate of 0.9, CRP elevated at 15.10, D-dimer elevated at 2214, ferritin elevated at 337.8, procalcitonin within normal limits at 0.10, influenza a and B PCR negative, RSV PCR negative, COVID-19 PCR positive.  UA appears contaminated and urine cultures currently pending.  C diff PCR positive.  Troponin x4 within normal limits.  EKG with sinus tachycardia, heart rate 111, T-wave abnormalities noted in inferior and lateral leads.  Chest x-ray within normal limits.  CT abdomen pelvis with contrast showed diffuse rocking pharyngeal mucosal thickening of the distal half with descending colon and sigmoid colon possibly due to colitis or diverticulitis extent of mucosal thickening in the colon slightly increased since previous exam. She continued to be asymptomatic for COVID during her hospital stay.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Anticoagulant therapy, COVID-19 pneumonia, Exposure during pregnancy, Sepsis, Tachycardia foetal
Clinical narrative: Admission Date: 7/28/2022 Discharge Date: 8/2/2022  HOSPITAL COURSE: Pt is a 35 yo G7P3033 at 36wk admitted to hospital with sepsis due to covid pneumonia. She was started on antivirals and steriods. She did require oxygen. By hospital day 5 she was no longer requiring supplemental oxygen. She was discharged home in stable condition to complete her course of azithromycin and methylprednisolone. She will need to complete another 5 days of prophylactic heparin.   Patient did not deliver during hospital stay and is currently still pregnant. Fetal well being: -  Cat I: baseline 150 bpm, moderate variability, accels present, decels absent              - initially had fetal tachycardia in 160s for 20 minutes but resolved - US 7/6/22: EFW 2213, 57%ile | AC 63%ile | AFI 10cm | anterior placenta  EDD:    08/24/22
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Ultrasound antenatal screen abnormal
Clinical narrative: Admission Date: 7/28/2022 Discharge Date: 8/2/2022  HOSPITAL COURSE: Pt is a 35 yo G7P3033 at 36wk admitted to hospital with sepsis due to covid pneumonia. She was started on antivirals and steriods. She did require oxygen. By hospital day 5 she was no longer requiring supplemental oxygen. She was discharged home in stable condition to complete her course of azithromycin and methylprednisolone. She will need to complete another 5 days of prophylactic heparin.   Patient did not deliver during hospital stay and is currently still pregnant. Fetal well being: -  Cat I: baseline 150 bpm, moderate variability, accels present, decels absent              - initially had fetal tachycardia in 160s for 20 minutes but resolved - US 7/6/22: EFW 2213, 57%ile | AC 63%ile | AFI 10cm | anterior placenta  EDD:    08/24/22
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Dose given out of vial opened 08/05/22 at 1400.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Hypoaesthesia, Muscle spasms, Neurological symptom, Pain
Clinical narrative: None stated.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: None stated.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Aspiration, COVID-19, Computerised tomogram thorax abnormal, Dyspnoea, Intensive care
Clinical narrative: Admitted on 7/21 with shortness of breath. Placed on Vapotherm in the ED and found bilateral confluent nodular consolidative pulmonary opacities on CT scan. Had a positive home COVID test on 7/18. Started on decadron and doxycycline and sent to critical care. Started remdesivir. ID was consulted and started on ceftaroline and zyvox due to concerns of superimposed bacterial infection with MRSA. On 7/24 family decided to make patient DNR. Switched from zyvox to daptomycin then to oxacillin also. Weaned patient down to 3L via nasal cannula. On 7/26 patient pulled our NG tube partially and aspirated. Desatted and required BiPAP and place on levophed for BP support. Family decided to move to comfort care.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Lung consolidation, Lung opacity, Medical device removal, Oxygen saturation decreased, Positive airway pressure therapy
Clinical narrative: Admitted on 7/21 with shortness of breath. Placed on Vapotherm in the ED and found bilateral confluent nodular consolidative pulmonary opacities on CT scan. Had a positive home COVID test on 7/18. Started on decadron and doxycycline and sent to critical care. Started remdesivir. ID was consulted and started on ceftaroline and zyvox due to concerns of superimposed bacterial infection with MRSA. On 7/24 family decided to make patient DNR. Switched from zyvox to daptomycin then to oxacillin also. Weaned patient down to 3L via nasal cannula. On 7/26 patient pulled our NG tube partially and aspirated. Desatted and required BiPAP and place on levophed for BP support. Family decided to move to comfort care.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Pulmonary mass, Respiratory therapy, SARS-CoV-2 test positive
Clinical narrative: Admitted on 7/21 with shortness of breath. Placed on Vapotherm in the ED and found bilateral confluent nodular consolidative pulmonary opacities on CT scan. Had a positive home COVID test on 7/18. Started on decadron and doxycycline and sent to critical care. Started remdesivir. ID was consulted and started on ceftaroline and zyvox due to concerns of superimposed bacterial infection with MRSA. On 7/24 family decided to make patient DNR. Switched from zyvox to daptomycin then to oxacillin also. Weaned patient down to 3L via nasal cannula. On 7/26 patient pulled our NG tube partially and aspirated. Desatted and required BiPAP and place on levophed for BP support. Family decided to move to comfort care.
Age: 9.0
Sex: F
Vaccine: COVID19
Symptoms: Loss of consciousness, Pain in extremity
Clinical narrative: After obtaining informed consent, Pfizer COVID booster 5 to 11 yr was given by CMA.  Pfizer COVID Booster IM Right Deltoid  Patient tolerated vaccine well at first then patient passed out. Father placed patient on table and I called for RN in Pediatrics to come in and assess patient.   CMA August 4, 2022 2:44 PM  RN called to room as patient passed out after receiving Pfizer COVID booster.    Patient awake and alert, lying on exam table with feet elevated. Dad fanning her with hat. She was able to verbalize her name, that her vision was normal and that she was not in any pain.    Obtained ice pack to place on her forehead, initiated vital sign assessment and requested in house pediatrician be notified to come assess patient.   Initial vital signs BP 70s/40s, HR 40s (adult attachment), SpO2 100%. Pediatric provider arrived to assess patient. Repeat vital signs BP 80s/50s, HR 50s (pediatric attachment), SpO2 100%. Patient stable per provider, ok to continue to monitor and discharge as appropriate.    Per parent this has happened before with shots. Patients PCP has recommended they pre-treat with Benadryl due to patient anxiety around shots and they did give her a dose before today's appointment.    Continuous pulse ox and heart rate left on patient to monitor. SpO2 continued steady at 100% and HR eventually came up into 70s/80s. Able to transition patient to sitting with legs elevated then to sitting with legs dangling. She tolerated well and was able to sip on ice water.    Around 1505 patient able to transition to standing without dizziness and ambulated independently. Discharged without assistance. In house pediatric provider updated.   8/5/2022 Called mom to follow up on patient status. She states patient did well overnight, no complaints other than some arm soreness. She is going great this morning as well.
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Patient died on 03/03/2022, death was not considered COVID related.
Age: 58.0
Sex: F
Vaccine: VARZOS
Symptoms: Dysphagia, Pharyngeal swelling, Swollen tongue, Throat clearing, Tongue disorder
Clinical narrative: Patient had Shingrix shot.  After 10 minutes she started to have reaction. Her tongue started to have bumps and then she felt her tongue is getting swollen and then feeling of her throat being swollen. She was ablet to breath all the time wasn't dizzy or anything. She was able to drink water. But she did feel she is having difficulty swallowing and had to clear her throat.  She denied to get EPI pen as she was able to breath all the time. She took 3 benadryl and was fully recovered after 2 hours.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chest discomfort, Dizziness, Fatigue, Headache
Clinical narrative: Headache, lower back pain, severe pain to my left arm, dizziness, fatigue, persistent feeling that something is in my chest
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Headache, lower back pain, severe pain to my left arm, dizziness, fatigue, persistent feeling that something is in my chest
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: covid positive hospitalized pt fully vaccinated
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: covid vaccine breakthrough case  dose 1 Moderna 3/3/21 029A21A dose 2 Moderna 3/31/21 045A21A dose 3 Moderna 11/16/21 058F21A
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: covid vaccine breakthrough case dose 1 Moderna 08/10/2021 939902
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: The facility did not have a prior history of COVID vaccinations on this patient so a primary series was to be started. The patient's form was originally marked for a booster dose so a half dose was given in the right arm and then it was determined the patient needed a 1st dose so the patient was given another half dose in the left arm. Based on the state database this was the 3rd dose and should of been a booster dose.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Blood test, Electromyogram, Nerve conduction studies abnormal, Nervous system disorder
Clinical narrative: Bilateral peripheral neuropathy, feet; also aggecting hands and arms to a lesser extent.  Permanent loss of sensation in toes and sole of foot/loss of balance.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Neuropathy peripheral, Sensory loss
Clinical narrative: Bilateral peripheral neuropathy, feet; also aggecting hands and arms to a lesser extent.  Permanent loss of sensation in toes and sole of foot/loss of balance.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Exposure to SARS-CoV-2, Oropharyngeal pain, SARS-CoV-2 test positive, Sleep disorder
Clinical narrative: I woke up with a sore throat in the middle of the night of July 3/4, 2022. On July 4, 2022, I took a nasal swab to test for COVID-19. The result was negative. Knowing I had been exposed (my husband had tested positive a week earlier), I took a second test and swabbed my throat instead; that test was positive.
Age: 81.0
Sex: F
Vaccine: FLUA4, VARZOS
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: Patient experienced swelling, redness and itching at both injection sites. She took benadryl OTC and her symptoms improved.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: The facility did not have a prior history of COVID vaccinations on this patient and they were trying to complete a primary series what they thought was needed, a 2nd dose. Based on the state database, this was the patient's 4th dose, but a full dose of Moderna was given.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: covid 19 positive pt hospitalized.  fully vaccinated
Age: 53.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: covid vaccine breakthrough  dose 1 Moderna 2/15/21 015M20A
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Malaise, SARS-CoV-2 test positive
Clinical narrative: hospitalized 8/2/2022 due to symptoms of COVID,
Age: 90.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Fully vaccinated with one booster.   COVID breakthrough infection
Age: 0.83
Sex: M
Vaccine: COVID19
Symptoms: Decreased appetite, Fatigue, Flushing, Insomnia, Irritability
Clinical narrative: Approximately 30 hours after vaccination we had noticed that he developed a fever. I gave him a dose of ibuprofen and around 4 AM he woke up, was warm to the touch and fussy. He fell asleep around 06:00AM and that next day he was with my mother-in-law and he was very flushed, lethargic, and fatigued. He was not able to calm down or sleep. 48 hours after vaccination he was presenting a fever of 104.4 and was very flush. He would wake up periodically with a fever and the next day we made an appointment to make sure everything was okay. I did an active COVID-19 swab at home and it was negative. At the pediatrician recommended MOTRIN and TYLENOL, and urine analysis came back clean however, on Saturday the results of the analysis then came back to 10,000+ colonies. KEFLEX was started on Sunday afternoon. He was beginning to have a lot of diarrhea on the KEFLEX, and so we got off of it. No active fevers, appetite is back, and much happier now.
Age: 0.83
Sex: M
Vaccine: COVID19
Symptoms: Lethargy, Pyrexia, SARS-CoV-2 test negative, Skin warm, Urine analysis abnormal
Clinical narrative: Approximately 30 hours after vaccination we had noticed that he developed a fever. I gave him a dose of ibuprofen and around 4 AM he woke up, was warm to the touch and fussy. He fell asleep around 06:00AM and that next day he was with my mother-in-law and he was very flushed, lethargic, and fatigued. He was not able to calm down or sleep. 48 hours after vaccination he was presenting a fever of 104.4 and was very flush. He would wake up periodically with a fever and the next day we made an appointment to make sure everything was okay. I did an active COVID-19 swab at home and it was negative. At the pediatrician recommended MOTRIN and TYLENOL, and urine analysis came back clean however, on Saturday the results of the analysis then came back to 10,000+ colonies. KEFLEX was started on Sunday afternoon. He was beginning to have a lot of diarrhea on the KEFLEX, and so we got off of it. No active fevers, appetite is back, and much happier now.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, SARS-CoV-2 test positive
Clinical narrative: Acute respiratory Failure, COVID positive, hospitalized
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: covid breakthrough event  dose 1 Moderna 2/12/21 029L20A dose 2 Moderna 3/12/21 010A21A
Age: 93.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Fully vaccinated with one booster.   COVID breakthrough infection
Age: 0.5
Sex: M
Vaccine: RV5
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: Patient arrives today for update of immunizations. Per note - "Behind on shots, will come back in 1-2 weeks for next set. Prefer to do 2 shots at a time."   Spoke with father asking which vaccinations patient is to have today with delayed schedule, father unsure. Patient has not received any 6 month immunizations yet. Discussed which 6 month vaccinations are typically due (pediarix, prevnar 13, and rotateq). Father states they only do two vaccinations at a time, prefers to do one injection and the oral.    Rotateq (oral) & pediarix (IM injection) discussed with father prior to administration. Administered to patient, he tolerated well.    4-month Rotateq immunization was administered at office visit on 7/13/22. Per Merck's guidelines, Rotateq immunizations are to be given at least 4 weeks apart. 6 month Rotateq given two weeks early.    PCP out of office, Dr. informed in office, he states to inform patient's mother/father that patient may experience mild abdominal discomfort/diarrhea. If symptoms persist or worsen, go to ER. This nurse called mother at 4:45pm 7/27/22 and left message to call back.    Spoke with mother this morning 7/28/22, relayed message. Mother voiced understanding. Asked for condition update on patient, she states patient has been acting his normal self, no concerns at this time. No adverse reaction. Instructed mother to call back at office if she has any concerns or questions.
Age: 79.0
Sex: F
Vaccine: UNK
Symptoms: Extra dose administered
Clinical narrative: 5TH DOSE GIVEN, NO ADVERSE REACTIONS
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Improper administration due to expired vaccine on July 13, 2022. Patient didn't report of any side effects or other outcomes.  Health Center was notified that once vaccine is received it can be kept in the freezer for 6 months. To prevent it from happening again, we will use the vaccine expiration tool to know the exact expiration date.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Improper administration due to expired vaccine on July 13, 2022. Patient didn't report of any side effects or other outcomes.  Health Center was notified that once vaccine is received it can be kept in the freezer for 6 months. To prevent it from happening again, we will use the vaccine expiration tool to know the exact expiration date.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: CSF protein increased, Computerised tomogram, Guillain-Barre syndrome, Hypoaesthesia, Lumbar puncture abnormal
Clinical narrative: was taken to the hospital ER on 7/29/2022 with numbness in her lower extremities.  She has been in the hospital since that day.  Friday  August 5, 2022, she was diagnosed with Guillain-Barre Syndrome and is totally paralyzed from the chest down at this point.  Doctors are sending her to a rehab center aftercare in the next few days.  She has no use of her legs and has no feeling from just under her breast to her ankles with extreme neuropathy in both feet.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging, Movement disorder, Neuropathy peripheral, Paralysis, Sensory loss
Clinical narrative: was taken to the hospital ER on 7/29/2022 with numbness in her lower extremities.  She has been in the hospital since that day.  Friday  August 5, 2022, she was diagnosed with Guillain-Barre Syndrome and is totally paralyzed from the chest down at this point.  Doctors are sending her to a rehab center aftercare in the next few days.  She has no use of her legs and has no feeling from just under her breast to her ankles with extreme neuropathy in both feet.
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient had a vaccine today 08-08-22 but the vaccine was expire.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Improper administration due to expired vaccine on July 13, 2022. Patient didn't report of any side effects or other outcomes.  Health Center was notified that once vaccine is received it can be kept in the freezer for 6 months. To prevent it from happening again, we will use the vaccine expiration tool to know the exact expiration date.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, C-reactive protein, Catheterisation cardiac normal, Chest X-ray, Chest pain
Clinical narrative: He had the onset of chest pain after dinner 8/6. He took ibuprofen and went to bed. No associated dyspnea, dizziness, diaphoresis or nausea. He woke up at 3am and the pain was gone. The pain recurred later in the morning and he presented to the ED. EKG with subtle ST elevation/J point elevation in the inferior and anterior leads. Mild pain in the ED. First troponin 2931. Underwent LHC showing clean coronaries. Started on DAPT with ASA and plavix. Troponins up trending to 5500.   Underwent ECHO showing Takotsubo cardiomyopathy with LVEF 40-45%. Started on colchicine 0.6 mg and ibuprofen 600 mg TID.  In settign of low EF, started on toprol 25 mg and losartan 25 mg.  Will undergo cardiac MRI today.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Differential white blood cell count, Echocardiogram abnormal, Ejection fraction, Electrocardiogram ST segment elevation, Fibrin D dimer
Clinical narrative: He had the onset of chest pain after dinner 8/6. He took ibuprofen and went to bed. No associated dyspnea, dizziness, diaphoresis or nausea. He woke up at 3am and the pain was gone. The pain recurred later in the morning and he presented to the ED. EKG with subtle ST elevation/J point elevation in the inferior and anterior leads. Mild pain in the ED. First troponin 2931. Underwent LHC showing clean coronaries. Started on DAPT with ASA and plavix. Troponins up trending to 5500.   Underwent ECHO showing Takotsubo cardiomyopathy with LVEF 40-45%. Started on colchicine 0.6 mg and ibuprofen 600 mg TID.  In settign of low EF, started on toprol 25 mg and losartan 25 mg.  Will undergo cardiac MRI today.